Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Berlin
  • Sector: Health Care
  • Industry: Medical Equipment & Devices
  • Sub-Industry: Medical Devices

3M4:GR

31.925 EUR 0.215 0.68%

As of 09:34:54 ET on 05/22/2015.

Snapshot for Masimo Corp (3M4)

Open: 31.510 Day's Range: 31.510 - 31.925 Volume: 0
Previous Close: 31.710 52wk Range: 15.935 - 32.735 1-Yr Rtn: +78.11%

Stock Chart for 3M4

No chart data available.
  • 3M4:GR 31.925
  • 1D
  • 1M
  • 1Y
31.710
Interactive 3M4 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 3M4

Current P/E Ratio (ttm) -
Estimated P/E(12/2015) 26.1757
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2015) 1.3460
Est. PEG Ratio 1.5705
Market Cap (M EUR) 1,679.82
Shares Outstanding (M) 52.62
30 Day Average Volume 1
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend (USD) 1.0000
Dividend Ex-Date 11/23/2012
5 Year Dividend Growth -
Next Earnings Announcement 08/07/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 3M4

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for 3M4

Masimo Corporation designs, develops and licenses medical signal processing and sensor technology for the noninvasive monitoring of physiological parameters. The Company's first products are designed to improve the effectiveness of pulse oximetry by overcoming the inability of current monitors to precisely measure the levels of arterial blood oxygen saturation and low arterial blood flow.

Joe E KianiChairman/CEO/FounderAnand SampathChief Operating Officer
Jon C ColemanPres:Worldwide SaleRick FishelPres:Worldwide OEM Business
More Company Profile & Key Executives for 3M4

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil